|MINERAL AND BONE DISORDER (MBD)||STATUS|
|KHA-CARI guideline: Biochemical and haematological targets: Haemoglobin concentrations in patients using erythropoietin-stimulating agents. McMahon LP, Macginley R. Nephrology 2012; 17(1): 17-9.||KHA-CARI Guideline: Use of iron in chronic kidney disease patients. MacGinley R, Walker R, Irving M. Nephrology 2013; 18(12): 747-9.|
Readers of these guidelines are advised to also refer to the guidelines contained in the "Vitamin D, Calcimimetics and Phosphate Binders" (Chronic Kidney Disease) section.